International Stem Cell Corporation Stock
Equities
ISCO
US4603782016
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 USD | 0.00% | -17.43% | +45.16% |
Financials (USD)
Sales 2022 | 8.18M | Sales 2023 | 7.79M | Capitalization | 496K |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | 0.61 x |
Net Debt 2022 | 3.53M | Net Debt 2023 | 2.59M | EV / Sales 2023 | 0.4 x |
P/E ratio 2022 |
-4.35
x | P/E ratio 2023 |
-3.79
x | Employees | 29 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 27.91% |
1 week | -17.43% | ||
Current month | -9.55% | ||
1 month | +47.06% | ||
3 months | +16.13% | ||
6 months | -27.07% | ||
Current year | +45.16% |
Managers | Title | Age | Since |
---|---|---|---|
Andrey Semechkin
CEO | Chief Executive Officer | 64 | 08-11-30 |
Russell Kern
DFI | Director of Finance/CFO | 38 | 08-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Russell Kern
DFI | Director of Finance/CFO | 38 | 08-09-30 |
Paul Maier
BRD | Director/Board Member | 76 | 07-06-30 |
Andrey Semechkin
CEO | Chief Executive Officer | 64 | 08-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.09 | 0.00% | 2,083 |
24-05-23 | 0.09 | -17.43% | 334 |
24-05-22 | 0.109 | 0.00% | 1,000 |
24-05-21 | 0.109 | +21.11% | 2,676 |
Delayed Quote OTC Markets, May 28, 2024 at 12:20 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+45.16% | 720K | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- ISCO Stock